On December 16, 2015, the National Institutes of Health (NIH) released an agency-wide strategic plan. This document does not replace the strategic planning process of the individual institutes and centers (ICs), rather it serves as an overarching framework for all of the ICs to incorporate into their strategic planning for the future. Development of the plan fulfills a request from Congress.

The overarching theme of the NIH-wide strategic plan is a clear emphasis on data collection and sharing to broaden the reach and impact of NIH investments moving forward. It consists of four strategic objectives for the agency: (1) to advance opportunities in biomedical research; (2) to foster innovation by setting NIH priorities, (3) to enhance scientific stewardship, and (4) to excel as a federal agency by managing for results.

GSA was pleased to see the interdependence of fundamental science, treatments and cures, and disease prevention as a key focus for the first objective, with fundamental science at the fore. The plan contains an in-depth discussion which connects findings from basic research to applications that have allowed the nation’s healthcare and diagnostic abilities to be more streamlined. One example noted is that of GSA member and 2008 Nobel Laureate Martin Chalfie, whose discovery of green fluorescent protein in jellyfish led to the protein becoming a widely used tool for observing biological processes. The development of the CRISPR/Cas9 technology was also mentioned as a clear breakthrough in the fundamental research community, as it has democratized gene editing and expanded its potential applications in animals and humans. This strong endorsement for fundamental research by the NIH is welcomed, as GSA continues to advocate for support of research aimed at improving scientific understanding.

Graph

Example of data that will be publicly available across IC’s showing the payline for R01 research grants. From p. 28 of the NIH Strategic Plan

The second objective focuses on a data-driven approach to setting funding priorities for the agency. NIH renewed its commitment to transparent, evidence-based processes that consider scientific opportunity, burden of disease, the importance of rare diseases, and the value of permanently eradicating a disease. NIH institutes and centers (ICs) will be encouraged to make funding rates, pay lines (the minimum score a grant application should receive to be funded), and data comparing scores to awards publicly available each year. This step would allow clear data comparisons to be made between ICs and would make the process of portfolio balance more visible to the public.

The third objective, enhancing scientific stewardship, speaks toward what the plan calls “the most valuable resource”—the scientific workforce.  Efforts to recruit and retain new and early career investigators by improving opportunities through new grant mechanisms are outlined in this section.  Award mechanisms meant to geographically broaden the workforce, shorten time to independence, prepare students and postdocs for a broader range of careers, and improve racial and ethnic diversity will all be evaluated to determine their level of success, emphasizing the renewed focus on data-centered decision making.  NIH also plans to put forward new approaches, such as training modules, open access publication policies, and data sharing, to bolster rigor and reproducibility in scientific research results. In addition, the agency will pursue a pilot study to investigate whether funding researchers rather than projects leads to a more diverse portfolio of science at the NIH. This is part of an effort to encourage innovation through supporting high-risk, high-reward research, strengthening partnerships with the private and non-profit sectors, and investing in emerging technologies.

The final objective, to excel as an agency by managing for results, places the development of actionable data across the NIH a clear priority.  Normalized metrics to be used for data analysis across ICs, robust bibliometric measures for scientific productivity, and an alignment of outputs with outcomes, were cited as areas where the agency will strengthen its portfolio analysis and reporting capabilities. In addition, NIH plans to be more inward looking, ramping up activities such as conducting “reviews of peer review,”  tracking the effectiveness of risk management in decision making, and reducing administrative burden.

The NIH strategic plan comes after months of public meetings and webinars where members of the scientific community openly shared comments, questions, and concerns about the proposed plan. The framework does not account for the recently passed appropriations bill which contains a $2 billion increase for the agency.

The full strategic plan can be found here.

, , , ,

Chloe Poston is the Policy and Communications Manager for the Genetics Society of America where she serves as a liaison to the Public Policy Committee. She has a background in bio-analytical chemistry and science policy.

View all posts by Chloe Poston »

Read more in

  • Ed Grell at his dissecting microscope using ether to anesthetize his flies.

    In Memoriam: Ellsworth Herman Grell (1932–2023), a pioneer of Drosophila genome engineering and annotation

    Ellsworth (Ed) Grell blessed the Drosophila community through three enduring legacies: as a pioneer of chromosome mechanics, as a primary organizer and synthesizer of genetic knowledge in Drosophila, and as a graceful mentor to those fortunate to have known him personally. Ed grew up in rural Nebraska, completed his undergraduate studies at Iowa State, and…

  • Congratulations to the #Fungal24 Poster Award winners!

    We are pleased to announce the recipients of the GSA Poster Awards for posters presented at the 32nd Fungal Genetics Conference! Undergraduate and graduate student members of GSA were eligible for the awards, and a hard-working team of judges made the determinations. Congratulations to all! Felicia Ebot Ojong, The University of Georgia My research is focused…

  • Poster presentation tips for TAGC 2024

    You’ve been selected to present a poster at The Allied Genetics Conference 2024 in March—you’ve celebrated, made plans to attend, now what? This is an exciting opportunity to showcase your research and engage with fellow members of the genetics community, so you want to make sure you’re prepared. We wanted to offer you some tips…

  • Maximize your TAGC 2024 experience 

    A guide to all that National Harbor & DC have to offer Are you joining us for The Allied Genetics Conference 2024 in March? Make the most of your #TAGC24 experience in National Harbor! We know the science will keep you busy, but you deserve to unwind and have some fun, so we’ve curated a…

  • Early Career Leadership Spotlight: Sarah Petrosky

    We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah PetroskyMultimedia SubcommitteeUniversity of Pittsburgh Research Interest I am interested in understanding adaptation that has been happening recently in populations by dissecting the ways that genes underlying an adaptation…

  • TAGC 2024 Early Career Award Winners

    GSA is pleased to announce the winners of the early career awards presented at The Allied Genetics Conference 2024. These awards are specific to particular TAGC communities and recognize early career scientists’ outstanding work on their respective research organisms. The awardees will present their talks in keynote sessions at TAGC 2024.  Don’t miss the opportunity…

  • Preeminent geneticists recognized with revamped GSA Awards

    In 2022, GSA’s Board of Directors launched an audit to review the five major awards conferred by the Society. Today, we are thrilled to announce the recipients of the reimagined GSA Awards, including the new Genetics Society of America Early Career Medal. The scientists honored this year are recognized by their peers for their outstanding…

  • Fly Board funds outreach programs to spread the word about Drosophila research

    In 2020, the Fly Board voted to use part of its reserve fund to support efforts to increase trainee participation as well as equity and diversity in the Drosophila community. An awards committee decides how the money will be spent each year, and from 2020–2022, the committee posted a very broad call for applications from…

  • New members of the GSA Board of Directors: 2024–2026

    We are pleased to announce the election of four new leaders to the GSA Board of Directors: 2024 Vice President/2025 President Brenda Andrews Professor, University of Toronto It’s an honor to continue my association with the Society by serving as Vice President of the Board of Directors. I have broad knowledge of the ongoing activities…

  • A rose-ringed parakeet, one of three parrot species used in the study.

    Parrot plumage study aids breeders and endangered natural populations

    Yellow coloration is maladaptive in the wild but prized by breeders. People have long been fascinated with birds, which exhibit one of the widest ranges of coloration among vertebrates. Parrots, in particular, have captivated humans by their ability to mimic human speech and spectacular plumage. Brightly colored feathers are used primarily to attract mates, intimidate…

  • Early Career Leadership Spotlight: Sarah Gilmour

    We’re taking time to get to know the members of the GSA’s Early Career Scientist Committees. Join us to learn more about our early career scientist advocates. Sarah GilmourMultimedia SubcommitteeStowers Institute for Medical Research Research Interest Questions of evolution have always fascinated me. I am extremely fortunate to be starting out my research career in a…